NCAGE THERAPEUTICS SPÓŁKA AKCYJNA

Key data

Status

Active

KRS number

REGON

NIP/VAT code

VAT registration date

VAT status

Bankruptcy proceedings

No proceedings

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA

Contacts

Registered address

See on map

Website

WWW.NCAGE.ORG

Lowest

Highest reliabilityLowest reliability

Reliability

A - Highest

B - High

C - Average

D - Low

E - Lowest

Incorporation date

25/07/2024

Share capital

116,850.00 PLN

Primary activity

Research and experimental development on biotechnology (72.11.Z - PKD 2007)

Representatives

Representatives rights

JEŻELI ZARZĄD JEST WIELOOSOBOWY DO SKŁADANIA OŚWIADCZEŃ W IMIENIU SPÓŁKI UPRAWNIONY JEST PREZES ZARZĄDU DZIAŁAJĄCY ŁĄCZNIE Z PROKURENTEM, PREZES ZARZĄDU DZIAŁAJĄCY ŁĄCZNIE Z INNYM CZŁONKIEM ZARZĄDU LUB DWÓCH CZŁONKÓW ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE; W PRZYPADKU POWOŁANIA WICEPREZESA ZARZĄDU DO SPRAW FINANSOWYCH SPÓŁKA REPREZENTOWANA JEST PRZEZ CZŁONKA ZARZĄDU LUB PREZESA ZARZĄDU DZIAŁAJĄCYCH ŁĄCZNIE Z WICEPREZESEM ZARZĄDU DO SPRAW FINANSOWYCH

Representatives

Chairman of the management boardJohn Vincent Bason

Member of the management boardJonathan Heddle

Vice-president of the management boardChristopher Lewis Kaplan

Business linkages

Check business linkages of NCAGE THERAPEUTICS SPÓŁKA AKCYJNACheck business linkages of a natural personCheck business linkages chain between 2 subjects

Price: zł63.00 | 1.00 credit

Compliance screening

Check whether your partner is listed in sanctions or PEP registers, or linked to negative public information or law enforcement reports. Ensure business safety and compliance.

Order report

Price: zł76.22 | 1.00 credit

People

Representatives

Person	Title
John Vincent Bason	Chairman of the management board
Jonathan Heddle	Member of the management board
Christopher Lewis Kaplan	Vice-president of the management board
Aleksander Roman Kłósek	Supervisory authority member
Aleksander Kłósek	Supervisory authority member

Persons with Significant Control

This information is available in our reports and to subscription users.

Financial ratios

Net Profit (zł)

-3,040,041

Net Profit (zł)

-3,040,041

Financial report (Okredo)

Price: zł22.00
Premium users: 1.00 credit

Indicator
Turnover (zł)
Profit before tax (zł)
Net Profit (zł)
Working capital requirement (%) The working capital requirement indicator shows how much funds a company needs to develop and maintain a business.
Liquidity ratio liquidityRatio
Net profitability (%) This ratio is commonly referred to as a company’s “bottom line” and is a true indicator of a company’s profitability. It shows how much a net profit of € 1 (or other monetary unit) is generated by sales.
Equity (zł)
Current liabilities (zł)
Non current liabilities (zł)
Non-current Assets (zł)

2024
0
-3,040,041
-3,040,041
-
25.08
-
8,075,712
304,547
0
-

2024
0
-3,040,041
-3,040,041
-
25.08
-
8,075,712
304,547
0
-

Turnover (zł)

2024

Turnover (zł)

0 zł- *

Profit before tax (zł)

-3,040,041 zł- *

Net Profit (zł)

-3,040,041 zł- *

Working capital requirement (%)

Liquidity ratio

25.08 - *

Net profitability (%)

Equity (zł)

8,075,712 zł- *

Current liabilities (zł)

304,547 zł- *

Non current liabilities (zł)

0 zł- *

Non-current Assets (zł)

*over the last year starting selected period

Credit history

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

No. of unpaid debts

Largest debt

Amount of unpaid debts

€0.00

Oldest open debt

Credit report

Order report

Unpaid debts

Creditor/Data source	Debt amount	Debt date	Debt type
-	-	-	-

Debt payment history

Creditor/Data source	Debt amount	Debt date	Payment date	Debt type
-	-	-	-	-

Documents

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA Documents

Date	Description
03/09/2025	OD 01.01.2024 DO 31.12.2024

Frequently Asked Questions

What is the current status of NCAGE THERAPEUTICS SPÓŁKA AKCYJNA?

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA is currently Active. It was registered on 25/07/2024.

Where is NCAGE THERAPEUTICS SPÓŁKA AKCYJNA located?

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA is registered at UL. PROFESORA MICHAŁA BOBRZYŃSKIEGO 14, 30-348, KRAKÓW, POLSKA.

What does NCAGE THERAPEUTICS SPÓŁKA AKCYJNA do?

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA operates in the Research and experimental development on biotechnology (72.11.Z - PKD 2007) sector.

What is the annual turnover of NCAGE THERAPEUTICS SPÓŁKA AKCYJNA?

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA reported a turnover of 0 PLN in 2024.

What is the net profit of NCAGE THERAPEUTICS SPÓŁKA AKCYJNA?

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA reported a net profit of -3,040,041 PLN in 2024.

Is NCAGE THERAPEUTICS SPÓŁKA AKCYJNA a reliable company?

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA Pre-Score* rating is E, which indicates a very low level of reliability.

* The credit score is calculated based on financial data, payment history, and other risk indicators.

Does NCAGE THERAPEUTICS SPÓŁKA AKCYJNA have any unpaid debts?

NCAGE THERAPEUTICS SPÓŁKA AKCYJNA has no recorded unpaid debts.